At Multimed Inc., we strive to offer authors a great publishing experience. We created a survey to obtain feedback and comments from our authors, whic

CO-NEWSLETTER-LOGO surveyresults

At Multimed Inc., we strive to offer authors a great publishing experience. We created a survey to obtain feedback and comments from our authors, which included the following areas:

• Experience of the publishing process with Current Oncology
• What is important to them when deciding where to publish
• Important databases and indexing services

The online survey was sent to 2,491 Current Oncology authors. We received a total of 202 (8.1%) responses. The survey was open from April 2, 2013 – April 30, 2013.

It is through surveys that we are able to assess our progress and identify future oportunities for improvement. We are grateful to those who took the time to complete the survey.

With the results received, our goal is to continue to improve the experience of authors publishing with Current Oncology, while maintaining the high standards of the journal.

***

How do authors rate their experience of publishing with Current Oncology?

Respondents were asked to rate their experience based on different steps within the submission and publication process. Respondents were asked to rate on a scale of 5, with 5 being highly satisfied and 1 being very dissatisfied.

Key Findings
• 91% were highly satisfied or satisfied with our electronic submission system
• 93% were highly satisfied or satisfied with our manuscript preparation and submission guidelines
• 84% were highly satisfied or satisfied with time from submission to Editor decision
• 84% were highly satisfied or satisfied with the quality of reviewer comments
• 91% were highly satisfied or satisfied with the copyediting and proofreading process
• 92% were highly satisfied or satisfied with the quality of the final published article
• 82% were highly satisfied or satisfied with the publication timeline

89% were highly satisfied or satisfied with the overall publishing experience

***

Feedback from our authors

Respondents were asked to provide comments about their experience of publishing with Current Oncology. Some of the feedback we received is below:

"I've always enjoyed publishing in Current Oncology, especially when something would come up, the prompt attention to the matter on the part of the editorial team was much appreciated"

"Well-organized stream-lined approach"

"The quick publication timeline and regular email notifications regarding production progress were appreciated"

"Great feedback and quick responses to emails and queries"

"Extraordinary friendly follow up with authors"

"Overall, it was an efficient and helpful process, and I was very satisfied with the final results"

"Comparing with other journals, the review and publication process was very fluent"

"Excellent and helpful comments from the reviewers that enhanced the overall quality of the finished product!!"

"Very efficient and clear process throughout. Very satisfied with end product."

Below are some common areas where authors felt we could improve, and actions we are taking:

Time from submission to decision
• Over the past year, our editorial team has been working towards decreasing the timeline from submission to initial editorial decision to the author. Our current goal is a decision within 4 weeks of submission.

Publication timeline
• Upon acceptance, our goal is to have articles published within six months or less. In 2012, there was a 25% decrease in the publication timeline in comparison to 2011. With the ability to publish more articles in an issue through a combination of our print & online and e-only publication model, we are working towards a further decrease in publication timelines in 2013.

***

Top 5 important factors for our authors when deciding where to publish

Respondents were asked to rate items they consider important when deciding which journal to publish with. Respondents were asked to rate each item on a scale of 5, with 5 being very important and 1 being not important at all. The top 5 factors are below:

1. Reputation of the journal within research community
2. Timely review process
3. High journal impact factor
4. International reach of article
5. Rapid publication after acceptance

Did you know? Current Oncology is a Canadian publication with high impact and wide international reach as exemplified by:

• Impact factor of 2.473 (Journal Citation Reports, Thomson Reuters 2011)
• Over 11,000 website visits per month ; an 86% increase from 2012 (Google Analytics, April 2013)
• Visited by 128 countries (28% USA, 27% Canada and 45% Int’l)
• Over 47,000 article views in PubMed Central in April 2013 (82% increase from April 2012)

***

Important databases and indexing services

Respondents were asked to rate which databases and indexing services they consider important as an author. Respondents were asked to rate each item on a scale of 5, with 5 being very important and 1 being not important at all.

Key Findings
PubMed received the highest importance rating, with 96% of respondents rating the database as very important or important
• 83% of respondents rated PubMed Central as very important or important
• 80% of respondents rated Medline as very important or important

Did you know? Current Oncology is indexed in major databases including PubMed, PubMed Central, Science Citation Index Expanded (SciSearch), and Journal Citation Reports/Science Edition. We have recently submitted an application to Medline and hope to receive acceptance for inclusion in early 2014.

Submit to Current Oncology today!

Publishing or continuing to publish with a prestigious peer-reviewed and high-impact journal, such as Current Oncology, ensures your article is being read and cited by an increasing widespread audience. For these reasons we encourage you to consider submitting your articles to Current Oncology.

Other benefits of publishing with us:

• Open access publication model ensures high visibility and maximum exposure for your work
• High standard and rigorous peer review process
• Distributed in print gratis to the Canadian oncology community
• Impact factor of 2.473
• Indexed in PubMed, EMBASE (Excerpta Medica Database), CrossRef, DOAJ (Directory of Open Access Journals), EMCare, Science Citation Index Expanded (SciSearch), and Journal Citation Reports/Science Edition
• Tracked by Thomson Reuters (ISI), Scopus, and Google Scholar
• Published articles are sent to and immediately available in PubMed Central (PMC)
• Published manuscripts will be invited to participate in the Cancer Knowledge Network, Current Oncology’s interactive dialogue website
• Authors are granted specific rights for a large number of author uses

To find out more about submitting a manuscript to Current Oncology, please visit our “Information for Authors” page at www.current-oncology.com.

twitter
1px